Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Shares Issued (2020 - 2024)

BioAtla (BCAB) has 5 years of Shares Issued data on record, last reported at $9.0 million in Q4 2024.

  • For Q4 2024, Shares Issued rose 4897.33% year-over-year to $9.0 million; the TTM value through Sep 2025 reached $8.8 million, up 8955.67%, while the annual FY2024 figure was $9.2 million, N/A changed from the prior year.
  • Shares Issued reached $9.0 million in Q4 2024 per BCAB's latest filing, up from -$187000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $198.3 million in Q4 2020 and bottomed at -$74.9 million in Q4 2021.
  • Average Shares Issued over 5 years is $23.1 million, with a median of $270000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: plummeted 169.26% in 2023, then surged 4897.33% in 2024.
  • A 5-year view of Shares Issued shows it stood at $198.3 million in 2020, then plummeted by 137.75% to -$74.9 million in 2021, then skyrocketed by 100.36% to $270000.0 in 2022, then tumbled by 169.26% to -$187000.0 in 2023, then soared by 4897.33% to $9.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $9.0 million in Q4 2024, -$187000.0 in Q4 2023, and $14000.0 in Q3 2023.